ARCHIVES

FCRC Decision Due In 90 Days, Upton Says

This article is from The Cancer Letter archive.

Vol. 04 No. 47 | November 24, 1978

Download PDF Visit The Full Archive

Related Articles

ACS Board allocated $37.5 Million to Research; More Coming

February 20, 1987

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

NCI Increases R01 Grant Payline From 12th to 15th Percentile.

June 29, 2007

Letters: Subcommittee Report Full Of Errors, Gallo Attorney Says

February 3, 1995

Saffiotti Couldn’t Cope With Demands Of National Program, Rauscher Says In Letter To Kennedy

June 11, 1976

Letter to the Editor: Colleagues describe Bunn As Leader, Patient Advocate

January 12, 1996